AtaiBeckley awarded ‘Buy’ rating in initial coverage from Deutsche Bank analysts

AtaiBeckley awarded ‘Buy’ rating in initial coverage from Deutsche Bank analysts Proactive uses images sourced from Shutterstock Deutsche Bank has initiated coverage on AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) assigning a 'Buy' rating and setting a price target of $12, implying potential upside of around 320% from current levels. In a note to clients, analysts highlighted the company’s position in the emerging field of psychedelic medicine for mental health. “Recently, several psychedelic companies ha ...